Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1971 1
1972 5
1973 6
1974 10
1975 5
1976 2
1977 7
1978 9
1979 7
1980 12
1981 8
1982 10
1983 5
1984 4
1985 7
1986 8
1987 9
1988 10
1989 6
1990 12
1991 6
1992 9
1993 12
1994 22
1995 10
1996 9
1997 13
1998 8
1999 14
2000 13
2001 9
2002 9
2003 8
2004 16
2005 17
2006 21
2007 25
2008 16
2009 21
2010 23
2011 16
2012 18
2013 16
2014 13
2015 6
2016 14
2017 8
2018 6
2019 6
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

502 results
Results by year
Filters applied: . Clear all
Page 1
Prostate Cancer Screening.
Catalona WJ. Catalona WJ. Med Clin North Am. 2018 Mar;102(2):199-214. doi: 10.1016/j.mcna.2017.11.001. Med Clin North Am. 2018. PMID: 29406053 Free PMC article. Review.
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.
Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, Musolf A, Li Q, Holzinger E, Karyadi D, Cannon-Albright LA, Teerlink CC, Stanford JL, Isaacs WB, Xu J, Cooney KA, Lange EM, Schleutker J, Carpten JD, Powell IJ, Cussenot O, Cancel-Tassin G, Giles GG, MacInnis RJ, Maier C, Hsieh CL, Wiklund F, Catalona WJ, Foulkes WD, Mandal D, Eeles RA, Kote-Jarai Z, Bustamante CD, Schaid DJ, Hastie T, Ostrander EA, Bailey-Wilson JE, Radivojac P, Thibodeau SN, Whittemore AS, Sieh W. Ioannidis NM, et al. Among authors: catalona wj. Am J Hum Genet. 2016 Oct 6;99(4):877-885. doi: 10.1016/j.ajhg.2016.08.016. Epub 2016 Sep 22. Am J Hum Genet. 2016. PMID: 27666373 Free PMC article.
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression.
Song B, Park SH, Zhao JC, Fong KW, Li S, Lee Y, Yang YA, Sridhar S, Lu X, Abdulkadir SA, Vessella RL, Morrissey C, Kuzel TM, Catalona W, Yang X, Yu J. Song B, et al. Among authors: catalona w. J Clin Invest. 2019 Feb 1;129(2):569-582. doi: 10.1172/JCI122367. Epub 2018 Dec 18. J Clin Invest. 2019. PMID: 30511964 Free PMC article.
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG. Giri VN, et al. Among authors: catalona wj. J Clin Oncol. 2018 Feb 1;36(4):414-424. doi: 10.1200/JCO.2017.74.1173. Epub 2017 Dec 13. J Clin Oncol. 2018. PMID: 29236593 Free PMC article. Review.
Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, DeKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC. Catalona WJ, et al. J Urol. 2017 Feb;197(2S):S200-S207. doi: 10.1016/j.juro.2016.10.073. Epub 2016 Dec 22. J Urol. 2017. PMID: 28012755 Clinical Trial.
Approaches to urinary detection of prostate cancer.
Eskra JN, Rabizadeh D, Pavlovich CP, Catalona WJ, Luo J. Eskra JN, et al. Among authors: catalona wj. Prostate Cancer Prostatic Dis. 2019 Sep;22(3):362-381. doi: 10.1038/s41391-019-0127-4. Epub 2019 Jan 17. Prostate Cancer Prostatic Dis. 2019. PMID: 30655600 Free PMC article. Review.
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.
Carroll PR, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP 3rd, Kawachi MH, Kim S, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Moses KA, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenkle P, Vickers AJ, Wake R, Shead DA, Freedman-Cass DA. Carroll PR, et al. Among authors: catalona wj. J Natl Compr Canc Netw. 2016 May;14(5):509-19. doi: 10.6004/jnccn.2016.0060. J Natl Compr Canc Netw. 2016. PMID: 27160230
Inflammatory Bowel Disease and the Risk of Prostate Cancer.
Burns JA, Weiner AB, Catalona WJ, Li EV, Schaeffer EM, Hanauer SB, Strong S, Burns J, Hussain MHA, Kundu SD. Burns JA, et al. Among authors: catalona wj. Eur Urol. 2019 May;75(5):846-852. doi: 10.1016/j.eururo.2018.11.039. Epub 2018 Dec 4. Eur Urol. 2019. PMID: 30528221 Free PMC article.
EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells.
Sagar V, Vatapalli R, Lysy B, Pamarthy S, Anker JF, Rodriguez Y, Han H, Unno K, Stadler WM, Catalona WJ, Hussain M, Gill PS, Abdulkadir SA. Sagar V, et al. Among authors: catalona wj. Cell Death Dis. 2019 Oct 22;10(11):801. doi: 10.1038/s41419-019-2042-y. Cell Death Dis. 2019. PMID: 31641103 Free PMC article.
Urology.
Catalona WJ. Catalona WJ. JAMA. 1993 Jul 14;270(2):265-6. JAMA. 1993. PMID: 8315758 No abstract available.
502 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback